Showing results (351-360 of 1,138) with videos related to

Sort By:
Pageof 114
Toxicological Sciences : an Official Journal of the Society of Toxicology|March 14, 2022
Multi-Omics Strategies for Investigating the Microbiome in Toxicology ResearchEthan W Morgan, Gary H Perdew, Andrew D Patterson
Texas Medicine|July 6, 2000
Nutritional rickets still afflict children in north TexasM Shah, N Salhab, D Patterson, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|March 21, 2013
Using the Medical Research Council framework to develop a complex intervention to improve delivery of care for young people with type 1 diabetesC Eiser, B Johnson, S Brierley, et al.
British Journal of Cancer|July 30, 2009
Follow-up care for cancer survivors: views of the younger adultK Absolom, C Eiser, G Michel, et al.
Child: Care, Health and Development|December 15, 2010
Clinical outcomes and health-related quality of life (HRQOL) following haemopoietic stem cell transplantation (HSCT) for paediatric leukaemiaS-A Clarke, R Skinner, J Guest, et al.
British Journal of Cancer|July 30, 2009
Follow-up care for cancer survivors: the views of cliniciansD M Greenfield, K Absolom, C Eiser, et al.
Proteomics. Clinical Applications|December 8, 2010
Cancer biomarker discovery via low molecular weight serum proteome profiling - Where is the tumor?Michael T Davis, Paul Auger, Chris Spahr, et al.
Cryobiology|June 1, 1993
Prostaglandin E2, interleukin-1 alpha, and potassium release from artificial human skin after freeze-thaw injuryW Bowers, M Blaha, J Sankovich, et al.
Digestive Diseases (Basel, Switzerland)|March 2, 2017
Intestinal Farnesoid X Receptor Signaling Modulates Metabolic DiseaseFrank J Gonzalez, Changtao Jiang, Cen Xie, et al.
British Journal of Clinical Pharmacology|December 4, 2003
The effects of KT3-671, a new angiotensin II (AT 1) receptor blocker in mild to moderate hypertensionD Patterson, J Webster, G McInnes, et al.
Pageof 114